News
The company seeks to grow its network of pharmacies across the region.
The study will accumulate objective lifestyle data from around 2,000 participants.
The web-based brain health assessment tool enables early detection of cognitive decline.
Researchers found a 43.4% mean reduction in patient-rated obsessive-compulsive symptoms.
The company provides resources and care navigation for people who are assisting older family members or loved ones with disabilities.
The app has been recommended as an effective alternative to sleeping pills in the UK.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
The startup, which offers remote assessments for conditions like ADHD and dyslexia, emerged from stealth Friday with a total of $4.2 million in funding.
On the heels of a $9.2 million Series A, Mahmee CEO and cofounder Melissa Hanna discusses the fragmented maternal healthcare experience in the U.S.
The solution uses gamification to increase patient adherence.